SIRT2 and Parkinson disease: Furthermore, inhibitors of this enzyme protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson’s disease, and it has also been shown that inhibition of SIRT2 (another sirtuin protein) rescued α-synuclein toxicity and modified inclusion morphology in a cell model of Parkinson’s disease [60].